The Short-term Impact of Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) on Respiratory Function in Patients With Lung Cancer
1 other identifier
interventional
1
1 country
1
Brief Summary
The purpose of this study is to examine the short-term impact of Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) on respiratory function in patients with lung cancer. As a secondary outcome, this research will evaluate the effect of the music intervention on respiratory quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable lung-cancer
Started Feb 2024
Shorter than P25 for not_applicable lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 7, 2023
CompletedFirst Posted
Study publicly available on registry
December 15, 2023
CompletedStudy Start
First participant enrolled
February 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedSeptember 19, 2024
September 1, 2024
3 months
December 7, 2023
September 3, 2024
Conditions
Outcome Measures
Primary Outcomes (6)
Change in Maximum Phonation Time (MPT) in seconds
Maximum Phonation Time (MPT) measures the number of seconds a participant can sustain a phonated sound.
Baseline, up to 30-minutes (Post-Intervention)
Respiratory Rate
Measured by the number of breaths per minute
Up to 30-minutes
Change in Dyspnea measured by Dyspnea-12 Questionnaire
Scores range from 0 to 3. Higher scores suggest more severity in shortness of breath
Baseline, up to 1 month
Change in Dyspnea measured by Modified Borg Scale
Scores change from 0 to 10. Higher scores suggest more severity in shortness of breath
Baseline, up to 30-minutes (Post-Intervention)
Change in Respiratory Quality of Life measured by St.Georges Respiratory Questionnaire
A composite score will be obtained, ranging from 0 to 100. Higher scores indicate worst respiratory quality of life
Baseline, up to 1 month
Change in Dyspnea measured by Cancer Dyspnea Scale
Scores range from 1 (Not at all) to 5 (Very much). Higher scores suggest more severity of dyspnea
Baseline, up to 1 month
Study Arms (1)
Vocal Therapy Group
EXPERIMENTALParticipants in this group will receive Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) for up to three weeks
Interventions
Participants will receive 12 individual sessions, four times a week (i.e., any four days of seven days) over three weeks. Each session will be held virtually for 30-minutes. Vocal Intonation Therapy is a music therapy technique consisting of breathing and vocal exercises to target respiratory function and vocal quality.
Participants will receive 12 individual sessions, four times a week (i.e., any four days of seven days) over three weeks. Each session will be held virtually for 30-minutes. Therapeutic Singing is a music therapy technique used to work on the rehabilitation of vocal and respiratory function.
Eligibility Criteria
You may qualify if:
- Participants will include three patients diagnosed with lung cancer, stages I-III, who have undergone a thoracentesis or thoracotomy in the last 12 months. Thoracic surgical procedures include pulmonary lobectomy or cancer-related surgical procedure (e.g., pneumonectomy). This diagnosis must be made by the patient's oncologist and medical team.
- The age range will be 40 to 80 years old. Both female and male participants from any race and ethnicity will be included in the study.
- The study will include English and Spanish speakers only.
- Patients must have less than five years of voice training experience (e.g., choir, private voice lessons).
You may not qualify if:
- Patients in respiratory failure
- Individuals with severe neurological and hearing impairments.
- Patients with diagnosed dysphonia and individuals who have undergone a laryngectomy
- Participants that do not have access to an electronic device, either an iPad, tablet, or laptop, as well as reliable internet access. They will also need to have adequate knowledge of technology or participate with a caregiver who knows how to navigate Zoom.
- Participants who do not have access to a quiet space. Headphones are optional for this study.
- Prisoners
- Persons under the age of 40 or over the age of 80.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Miami
Coral Gables, Florida, 33146, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Teresa Lesiuk, PhD
University of Miami
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 7, 2023
First Posted
December 15, 2023
Study Start
February 21, 2024
Primary Completion
June 1, 2024
Study Completion
June 1, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share